Zhang, L., Chen, F., Geng, S., Wang, X., Gu, L., Lang, Y., . . . Ye, S. (2020). Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. J Inflamm Res.
Style de citation ChicagoZhang, Le, Fangfang Chen, Shikai Geng, Xiaodong Wang, Liyang Gu, Yitian Lang, Ting Li, et Shuang Ye. "Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients With MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World." J Inflamm Res 2020.
Style de citation MLAZhang, Le, et al. "Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients With MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World." J Inflamm Res 2020.